The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Vaccine adjuvants: Current challenges and future approaches
Open accessAbstract
For humans, companion animals, and food producing animals, vaccination has been touted as the most successful medical intervention for the prevention of disease in the twentieth century. However, vaccination is not without problems. With the development of new and less reactogenic vaccine antigens, which take advantage of molecular recombinant technologies, also comes the need for more effective adjuvants that will facilitate the induction of adaptive immune responses. Furthermore, current vaccine adjuvants are successful at generating humoral or antibody mediated protection but many diseases currently plaguing humans and animals, such as tuberculosis and malaria, require cell mediated immunity for adequate protection. A comprehensive discussion is presented of current vaccine adjuvants, their effects on the induction of immune responses, and vaccine adjuvants that have shown promise in recent literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules
Han, M., Gao, X., Su, J. Z., & Nie, S. (2001) · Nature Biotechnology · doi:10.1038/90228 · Cited by 2,631
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Biodegradable synthetic polymers for tissue engineering
CSIRO Molecular Science, B. 1., & Gunatillake, P. (2003) · European Cells and Materials · doi:10.22203/ecm.v005a01 · Cited by 1,765
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Lymphokine Control of In Vivo Immunoglobulin Isotype Selection
Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R., & Paul, W. E. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001511 · Cited by 1,300
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
Toll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,173
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Handbook of Pharmaceutical Controlled Release Technology
Wise, D. L. (2000) · CRC Press eBooks · doi:10.1201/9781482289985 · Cited by 768
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo
Villadangos, J. A., & Schnorrer, P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2103 · Cited by 702
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development
Pulendran, B., & Ahmed, R. (2006) · Cell · doi:10.1016/j.cell.2006.02.019 · Cited by 625
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Targeting the innate immune response with improved vaccine adjuvants
Pashine, A., Valiante, N. M., & Ulmer, J. B. (2005) · Nature Medicine · doi:10.1038/nm1210 · Cited by 555
Iwasaki, A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141634 · Cited by 534
Singh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
Toll-like Receptors and Innate Immunity
(2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)78001-7 · Cited by 496
Aguilar, J. C., & Rodríguez, E. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.111 · Cited by 494
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Encyclopedia of chemical processing
(2006) · Choice Reviews Online · doi:10.5860/choice.43-5632 · Cited by 416
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Controlled drug delivery : challenges and strategies
Park, K. (1997) · American Chemical Society eBooks · Cited by 403
Kumar, N., Langer, R. S., & Domb, A. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00050-9 · Cited by 394
Triggering TLR signaling in vaccination
van Duin, D., Medzhitov, R., & Shaw, A. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.005 · Cited by 364
The genome sequence of Clostridium tetani , the causative agent of tetanus disease
Brüggemann, H., Bäumer, S., Fricke, W. F., Wiezer, A., Liesegang, H., Decker, I., Herzberg, C., Martínez-Arias, R., Merkl, R., Henne, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0335853100 · Cited by 354
Jump-starting the immune system: prime–boosting comes of age
Woodland, D. L. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.009 · Cited by 346
T-cell regulation: with complements from innate immunity
Kemper, C., & Atkinson, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri1994 · Cited by 340
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
Podda, A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00499-0 · Cited by 333
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Adjuvant Properties of Aluminum and Calcium Compounds
Gupta, R. K., Rost, B. E., Relyveld, E., & Siber, G. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_8 · Cited by 330
Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90092-2 · Cited by 313
Toxicity, biodegradation and elimination of polyanhydrides
Katti, D. S., Lakshmi, S., Langer, R., & Laurencin, C. T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00052-2 · Cited by 305
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
The promise of cancer vaccines
Gilboa, E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1359 · Cited by 267
Self-Assembled Quantum Dot−Peptide Bioconjugates for Selective Intracellular Delivery
Delehanty, J. B., Medintz, I. L., Pons, T., Brunel, F. M., Dawson, P. E., & Mattoussi, H. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060044i · Cited by 264
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines
Wang, C., Ge, Q., Ting, D., Nguyen, D., Shen, H.-R., Chen, J., Eisen, H. N., Heller, J., Langer, R., & Putnam, D. (2004) · Nature Materials · doi:10.1038/nmat1075 · Cited by 262
Bioerodible polyanhydrides as drug‐carrier matrices. II. Biocompatibility and chemical reactivity
Leong, K. W., D'Amore, P., Marletta, M., & Langer, R. (1986) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820200106 · Cited by 261
Yip, H. C., Karulin, A. Y., Tary-Lehmann, M., Hesse, M. D., Radeke, H., Heeger, P. S., Trezza, R. P., Heinzel, F. P., Forsthuber, T., & Lehmann, P. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3942 · Cited by 258
Freytag, L. C., & Clements, J. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.010 · Cited by 252
O'Hagan, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00012-x · Cited by 243
Jackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C., Zeng, W., & Brown, L. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406740101 · Cited by 236
(How) do aluminium adjuvants work?
BREWER, J. (2006) · Immunology Letters · doi:10.1016/j.imlet.2005.08.002 · Cited by 236
Bioerodible polyanhydrides for controlled drug delivery
Rosen, H. B., Chang, J., Wnek, G. E., Linhardt, R. J., & Langer, R. (1983) · Biomaterials · doi:10.1016/0142-9612(83)90054-6 · Cited by 226
A Compendium of Vaccine Adjuvants and Excipients
Vogel, F. R., & Powell, M. F. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_7 · Cited by 217
Localization dose and time of antigens determine immune reactivity
Zinkernagel, R. M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0253 · Cited by 214
Jackson, R. J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C. O., & McGhee, J. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4272-4279.1993 · Cited by 207
Recent advances in veterinary vaccine adjuvants
Singh, M., & O'Hagan, D. T. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00053-5 · Cited by 207
The development of polyanhydrides for drug delivery applications
Tamada, J., & Langer, R. (1992) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856292x00402 · Cited by 207
Improving Vaccine Performance with Adjuvants
Vogel, F. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313883 · Cited by 202
Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers
Flo, T. H., Ryan, L., Latz, E., Takeuchi, O., Monks, B. G., Lien, E., Halaas, Ø., Akira, S., Skjåk-Bræk, G., Golenbock, D. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201366200 · Cited by 196
Uptake of poly(D,L‐lactic‐co‐glycolic acid) microspheres by antigen‐presenting cells in vivo
Newman, K. D., Elamanchili, P., Kwon, G. S., & Samuel, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10019 · Cited by 195
Guery, J. C., Galbiati, F., Smiroldo, S., & Adorini, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.485 · Cited by 192
Chong, C. S. W., Cao, M., Wong, W. W., Fischer, K. P., Addison, W. R., Kwon, G. S., Tyrrell, D. L., & Samuel, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.014 · Cited by 191
Diwan, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00275-4 · Cited by 177
New advances in microsphere-based single-dose vaccines
Hanes, J., Cleland, J. L., & Langer, R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00053-7 · Cited by 176
Kipper, M. J., Shen, E., Determan, A. S., & Narasimhan, B. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00181-3 · Cited by 175
Self-citationAudran, R., Peter, K., Dannull, J., Men, Y., Scandella, E., Groettrup, M., Gander, B., & Corradin, G. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00521-2 · Cited by 168
Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres
Tabata, Y., Gutta, S., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018929531410 · Cited by 167
New polymeric carriers for controlled drug delivery following inhalation or injection
Fu, J., Fiegel, J., Krauland, E., & Hanes, J. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00182-5 · Cited by 163
The contribution of immunology to the rational design of novel antibacterial vaccines
Kaufmann, S. H. E. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1688 · Cited by 162
Overview of vaccine adjuvants: present and future
Hunter, R. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00164-0 · Cited by 157
Rimaniol, A., Gras, G. S., Verdier, F., Capel, F., Grigoriev, V. B., Porcheray, F., Sauzeat, E., Fournier, J. G., Clayette, P., Siegrist, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.061 · Cited by 157
Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
Vasilakos, J. P., Smith, R. M., Gibson, S. J., Lindh, J. M., Pederson, L. K., Reiter, M. J., Smith, M. H., & Tomai, M. A. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1689 · Cited by 155
Toll or Toll-Free Adjuvant Path Toward the Optimal Vaccine Development
Ishii, K. J., & Akira, S. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9087-x · Cited by 151
Kim, W., Lee, W.-K., Ryoo, J., Kim, S., Kim, J., Youn, J., Min, S., Bae, E., Hwang, S., Park, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10198 · Cited by 150
Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres
Determan, A. S., Trewyn, B. G., Lin, V. S. ‐., Nilsen‐Hamilton, M., & Narasimhan, B. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.006 · Cited by 149
Self-citationChemical adjuvants for plasmid DNA vaccines
Greenland, J. R., & Letvin, N. L. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.120 · Cited by 146
Babensee, J. E., & Paranjpe, A. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30429 · Cited by 143
Aguado, M. T., & Lambert, P. H. (1992) · Immunobiology · doi:10.1016/s0171-2985(11)80470-5 · Cited by 141
Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M. M., Singh, O., & Panda, A. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00342-3 · Cited by 140
Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms
Torres, M. P., Vogel, B. M., Narasimhan, B., & Mallapragada, S. K. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30510 · Cited by 140
Self-citationResponses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1
Cunningham, A. F., Khan, M., Ball, J., Toellner, K., Serre, K., Mohr, E., & MacLennan, I. C. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425403 · Cited by 137
Single-administration vaccines: controlled-release technology to mimic repeated immunizations
Cleland, J. L. (1999) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01272-4 · Cited by 135
A novel bioadhesive intranasal delivery system for inactivated influenza vaccines
Singh, M., Briones, M., & O’Hagan, D. T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00330-8 · Cited by 135
Novel Approaches to Vaccine Delivery
O’Hagan, D. T., & Rappuoli, R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041443.17935.33 · Cited by 133
Rogers, P., & Croft, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2955 · Cited by 132
Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
Cox, E., Verdonck, F., Vanrompay, D. C. G., & Goddeeris, B. M. (2006) · Veterinary Research · doi:10.1051/vetres:2006014 · Cited by 130
Conway, M. A., Madrigal-Estebas, L., McClean, S., Brayden, D. J., & Mills, K. H. G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00433-3 · Cited by 130
Amphiphilic polyanhydrides for protein stabilization and release
Torres, M. P., Determan, A. S., Anderson, G. L., Mallapragada, S. K., & Narasimhan, B. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.047 · Cited by 126
Self-citationSalkowski, C. A., Detore, G. R., & Vogel, S. N. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3239-3247.1997 · Cited by 126
Shen, E., Kipper, M. J., Dziadul, B., Lim, M.-K., & Narasimhan, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00125-6 · Cited by 122
Self-citationKipper, M. J., Wilson, J. H., Wannemuehler, M. J., & Narasimhan, B. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30545 · Cited by 120
Self-citationEncapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., & O’Hagan, D. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.010 · Cited by 120
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Bowersock, T. L., & Martin, S. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00015-0 · Cited by 115
Development of Acellular Pertussis Vaccines
Sato, Y., & Sato, H. (1999) · Biologicals · doi:10.1006/biol.1999.0181 · Cited by 112
“Dirty little secrets”—Endotoxin contamination of recombinant proteins
Wakelin, S. J., Sabroe, I., Gregory, C. D., Poxton, I. R., Forsythe, J. L. R., Garden, O. J., & Howie, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.007 · Cited by 110
Differential signaling by CpG DNA in DCs and B cells: not just TLR9
Verthelyi, D. I., & Zeuner, R. A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00243-6 · Cited by 110
Determan, A. S., WILSON, J., Kipper, M. J., Wannemuehler, M. J., & Narasimhan, B. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.054 · Cited by 109
Self-citationVirosomes for antigen and DNA delivery
Daemen, T., DEMARE, A., Bungener, L. B., de Jonge, J., Huckriede, A. L. W., & Wilschut, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.005 · Cited by 109
Manipulating the immune system: humoral versus cell-mediated immunity
McNeela, E. A., & Mills, K. H. G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00169-7 · Cited by 106
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
Petrovsky, N. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.107 · Cited by 105
Dendritic cells in the recognition of intestinal microbiota
Niess, J. H., & Reinecker, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00694.x · Cited by 102
Cholera Toxin and its Subunits as Potential Oral Adjuvants
Elson, C. O. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74529-4_3 · Cited by 101
Microphase separation in bioerodible copolymers for drug delivery
Shen, E., Pizsczek, R., Dziadul, B., & Narasimhan, B. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00175-7 · Cited by 101
Self-citationTwo successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults
Watson-Creed, G. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060660 · Cited by 100
Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone
Erdmann, L., Macedo, B., & Uhrich, K. E. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00118-6 · Cited by 98
Boonyo, W., Junginger, H. E., Waranuch, N., Polnok, A., & Pitaksuteepong, T. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.025 · Cited by 98
Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Rk, G., Chang, A. C., & Siber, G. R. (1998) · PubMed · Cited by 98
Lopac, S. K., Torres, M. P., Wilson‐Welder, J. H., Wannemuehler, M. J., & Narasimhan, B. (2009) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31478 · Cited by 97
Self-citationCytokines: Making the right choice
Finkelman, F. D., & Urban, J. F. (1992) · Parasitology Today · doi:10.1016/0169-4758(92)90105-b · Cited by 97
Polyanhydrides: Synthesis and characterization
Domb, A. J., Amselem, S., Shah, J. C., & Maniar, M. L. (1993) · Advances in polymer science · doi:10.1007/bfb0027552 · Cited by 96
What it takes to become an effector T cell: The process, the cells involved, and the mechanisms
Santana, M. A., & Rosenstein, Y. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10258 · Cited by 96
Shibaki, A., & Katz, S. (2002) · Experimental Dermatology · doi:10.1034/j.1600-0625.2002.110204.x · Cited by 95
Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers
Mathiowitz, E., Ron, E., Mathiowitz, G., et al. (1990) · Macromolecules · doi:10.1021/ma00215a003 · Cited by 93
Hanes, J. S., Chiba, M., & Langer, R. (1998) · Biomaterials · doi:10.1016/s0142-9612(97)00221-4 · Cited by 92
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses
Lutsiak, M. E. C., Kwon, G. S., & Samuel, J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0004 · Cited by 89
Oral vaccination with alginate microsphere systems
Bowersock, T. L., HogenEsch, H., Suckow, M. A., Porter, R. E., Jackson, R., Park, H., & Park, K. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00155-7 · Cited by 88
Lynch, J. M., Briles, D. E., & Metzger, D. W. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4780-4788.2003 · Cited by 88
Controlled release of polypeptides from polyanhydrides.
Ron, E., Turek, T., Mathiowitz, E., Chasin, M., Hageman, M. J., & Langer, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4176 · Cited by 85
van Ginkel, F. W., Jackson, R. J., Yoshino, N., Hagiwara, Y., Metzger, D., Connell, T. D., Vu, H. L., Martin, M., Fujihashi, K., & McGhee, J. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6892-6902.2005 · Cited by 84
Newman, K. D., Samuel, J., & Kwon, G. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00142-9 · Cited by 83
Waeckerle‐Men, Y., Scandella, E., Allmen, E. U.-V., Ludewig, B., Gillessen, S., Merkle, H. P., Gander, B. A., & Groettrup, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.01.010 · Cited by 83
The preparation and characterization of polymeric antigen delivery systems for oral administration
Singh, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00044-1 · Cited by 81
The relevance of cytokines for development of protective immunity and rational design of vaccines
Chabalgoity, J. A., Baz, A., Rial, A., & Grille, S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.016 · Cited by 79
Singh, M., Vajdy, M., Gardner, J. P., Briones, M., & O’Hagan, D. T. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00321-8 · Cited by 78
The Innate Immune Response to Infection
Kaufmann, S. H. E., Medzhitov, R. M., & Gordon, S. (2004) · ASM Press eBooks · doi:10.1128/9781555817671 · Cited by 76
Borsutzky, S., Kretschmer, K., Becker, P. D., Mühlradt, P. F., Kirschning, C. J., Weiß, S., & Guzmán, C. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6308 · Cited by 75
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
Rook, G. A. W., Dheda, K. U. J., & Zumla, A. I. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.069 · Cited by 75
Experimental Leishmania major infection in mice: role of IL‐10
Châtelain, R., Mauze, S., & Coffman, R. L. (1999) · Parasite Immunology · doi:10.1046/j.1365-3024.1999.00224.x · Cited by 75
Sun, H., & Pan, H.-J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.040 · Cited by 75
Lacasse, F.-X., Filion, M. C., Phillips, N. C., Escher, E., McMullen, J. N., & Hildgen, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011935222652 · Cited by 72
Xing, D. K. L., Crane, D. T., Bolgiano, B., Corbel, M. J., Jones, C., & Sesardic, D. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00032-1 · Cited by 71
Newman, K. D., Sosnowski, D. L., Kwon, G. S., & Samuel, J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980070s · Cited by 69
Kammer, A. R., Amacker, M., Rasi, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.052 · Cited by 66
Particulate delivery systems for vaccines: what can we expect?
Bramwell, V. W., & Perrie, Y. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0002 · Cited by 65
Rk, G., Alroy, J., Alonso, M. J., Langer, R., & Siber, G. R. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00116-3 · Cited by 63
Bloom, B. R., & Lambert, P. H. (2003) · Academic Press eBooks · Cited by 62
Amidi, M., Pellikaan, H. C., Hirschberg, H. J. H. B., de Boer, A. H., Crommelin, D. J. A., Hennink, W. E., Kersten, G. F. A., & Jiskoot, W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.064 · Cited by 60
Exploiting receptor biology for oral vaccination with biodegradable particulates
Foster, N. M., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.009 · Cited by 60
Hsu, T., Hutto, D., Minion, F. C., Zuerner, R. L., & Wannemuehler, M. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.706-711.2001 · Cited by 59
Self-citationTargeting dendritic cells for priming cellular immune responses
Gogolák, P., Réthi, B., Hajas, G., & Rajnavölgyi, É. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.650 · Cited by 57
Kemp, J. M., Kajihara, M., Nagahara, S., Sano, A., Brandon, M. R., & Lofthouse, S. A. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00444-3 · Cited by 55
Trujillo-Vargas, C. M., Mayer, K. D., Bickert, T., Palmetshofer, A., Grunewald, S., Ramírez‐Pineda, J. R., Polte, T., Hansen, G., Wohlleben, G., & Erb, K. J. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02287.x · Cited by 55
Sun, H. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.030 · Cited by 52
Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams
Muñoz, P. M., Estevan, M., Marín, C. M., de Miguel, M. J., Grilló, M. J., Barberán, M., Irache, J. M., Blasco, J. M., & Gamazo, C. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.042 · Cited by 50
Vogel, B. M., & Mallapragada, S. K. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.03.024 · Cited by 50
Self-citationPeyre, M., Fleck, R. A., Hockley, D. J., Gander, B. A., & Sesardic, D. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.068 · Cited by 49
Jiang, W., & Schwendeman, S. P. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1106 · Cited by 49
Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine
Cui, C., Stevens, V. C., & Schwendeman, S. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.055 · Cited by 48
Heath, W. R., & Carbone, F. R. (2003) · Nature · doi:10.1038/425460a · Cited by 46
de Sousa, C. B. P., Santos, W. R., Casas, C. P., de Souza, E. P., Tinoco, L. W., da Silva, B. P., Palatnik, M., & Parente, J. P. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.072 · Cited by 44
Aluminium hydroxide-induced granulomas in pigs
Valtulini, S., Macchi, C., Ballanti, P., Chérel, Y., Laval, A., Theaker, J. M., Bak, M., Ferretti, E., & Morvan, H. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.06.058 · Cited by 43
Evans, J. T., Ward, J. R., Kern, J., & Johnson, M. E. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.035 · Cited by 39
Sedlik, C., Dériaud, E., & Leclerc, C. (1997) · International Immunology · doi:10.1093/intimm/9.1.91 · Cited by 39
Mata, E., Carcaboso, A. M., Hernández, R. M., Igartúa, M., Corradin, G., & Pedraz, J. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.036 · Cited by 39
Edelman, R., & Tacket, C. O. (1990) · International Reviews of Immunology · doi:10.3109/08830189009061764 · Cited by 39
Peyre, M., Sesardic, D., Merkle, H. P., Gander, B., & Johansen, P. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10361 · Cited by 36
Stertman, L., Strindelius, L., & Sjöholm, I. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.019 · Cited by 36
Hypothesis: How Licensed Vaccines Confer Protective Immunity
Robbins, J. B., Schneerson, R., & Szu, S. C. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1382-1_22 · Cited by 34
Lattanzi, M., & Rappuoli, R. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7381-4_5 · Cited by 33
CpG-activated Thy1.2+ dendritic cells protect against lethalListeria monocytogenes infection
Ishii, K. J., Ito, S., Tamura, T., Hemmi, H., Conover, J., Ozato, K., Akira, S., & Klinman, D. M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425795 · Cited by 31
Oral immunoadjuvant activity ofLactobacillus caseisubsp.caseiin dextran-fed layer chickens
Ogawa, T., Asai, Y., Sakamoto, H., & Yasuda, K. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051629 · Cited by 30
Tetanus toxoid loaded ‘preformed microspheres’ of cross-linked dextran
Diwan, M., Khar, R. K., & Talwar, G. P. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00140-2 · Cited by 28
Barth, H., Berg, P. A., & Klein, R. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02265.x · Cited by 25
Erosion of poly(anhydride-co-imides): A preliminary mechanistic study
Seidel, J., Uhrich, K. E., Laurencin, C. T., & Langer, R. (1996) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19961121)62:8<1277::aid-app18>3.0.co;2-4 · Cited by 24
Design of a core-shelled polymer cylinder for potential programmable drug delivery
Qiu, L., & Zhu, K. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00644-5 · Cited by 23
Shu, Q., Hillard, M. A., Bindon, B. M., Duan, E., Xu, Y., Bird, S. H., Rowe, J. B., Oddy, V. H., & Gill, H. S. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.839 · Cited by 20
Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker, K. B., Xing, D., Sesardic, D., & Corbel, M. J. (1998) · PubMed · Cited by 18
Mycobacterial ESAT-6 Protein Enhances Mouse IFN- γ Responses to Mycoplasma hyopneumoniae P71 Protein
Menon, S. A., Wannemuehler, M. J., Mahairas, G. G., & Minion, F. C. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002320271404 · Cited by 15
Self-citationFormulation of Poly(DL-Lactide-Co-Glycolide) Microspheres and Their Ingestion by Bovine Leukocytes
O’Brien, C. N., & Guidry, A. J. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76566-9 · Cited by 14
Comparative analysis of oral delivery systems for live rotavirus vaccines
Duncan, J. D., Wang, P. X., Harrington, C., et al. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01331-4 · Cited by 13
Uptake of antigen encapsulated in polyethylcyanoacrylate nanoparticles by D1-dendritic cells.
Pitaksuteepong, T., Davies, N. M., Baird, M. A., & Rades, T. (2004) · PubMed · Cited by 8
The Regulatory Role of Dendritic Cells in the Innate Immune Response
Granucci, F., Feau, S., Zanoni, I., Raimondi, G., Pavelka, N., Vizzardelli, C., & Ricciardi‐Castagnoli, P. (2014) · ASM Press eBooks · doi:10.1128/9781555817671.ch5 · Cited by 3
Cited by
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Pasquale, A., Preiss, S., Silva, F., & Garçon, N. (2015) · Vaccines · doi:10.3390/vaccines3020320 · Cited by 648
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Kamerzell, T. J., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.006 · Cited by 510
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
Kumru, O. S., Joshi, S. B., Smith, D. E., Middaugh, C. R., Prusik, T., & Volkin, D. B. (2014) · Biologicals · doi:10.1016/j.biologicals.2014.05.007 · Cited by 404
Metadata
- Authors
- Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J., & Narasimhan, B.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 98
- Issue
- 4
- Pages
- 1278-1316
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2050503449
- Cited by
- 296
- References
- 185
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.